Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Dominik Andreas Barth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0812-3024; OpenAlex author ID A5012484710. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: 1 paper

Papers 5

  1. Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel. Co-author DOI 10.1055/a-1548-4847↗
  2. Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. Co-author DOI 10.1016/j.ejca.2021.03.040↗
  3. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients. Co-author DOI 10.1002/cam4.3233↗
  4. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. First author DOI 10.3390/cancers12051154↗
  5. The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer. First author DOI 10.3390/cancers12071798↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Stotz · 5 shared papers, 2020–2022 · strength 0.53
  2. Armin Gerger · 5 shared papers, 2020–2022 · strength 0.53
  3. Jakob Michael Riedl · 5 shared papers, 2020–2022 · strength 0.53
  4. Martin Pichler Pichler · 5 shared papers, 2020–2022 · strength 0.53
  5. Konstantin Schlick · 4 shared papers, 2020–2022 · strength 0.43
  6. Peter Kornprat · 3 shared papers, 2020 · strength 0.30
  7. Eva Valentina Klocker · 3 shared papers, 2020 · strength 0.30
  8. Florian Moik · 2 shared papers, 2021–2022 · strength 0.23
  9. Richard Greil · 2 shared papers, 2021–2022 · strength 0.23
  10. Cihan Ay · 1 shared paper, 2022 · strength 0.12
  11. Eva Asamer · 1 shared paper, 2020 · strength 0.10
  12. Joanna Szkandera · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.